BusinessGreat Basin Scientific to Demonstrate its Diagnostics Platform at AMP 2016By Nasdaq OMXNov 10, 2016, 12:01 PM UTC
BusinessGreat Basin Scientific Completes Clinical Trial for Stool Bacterial Pathogens PanelBy Nasdaq OMXNov 8, 2016, 12:00 PM UTC
BusinessCempra to Present at the Needham and Company 15th Annual Healthcare ConferenceBy Nasdaq OMXApr 6, 2016, 11:30 AM UTC
BusinessSummit Announces Ridinilazole Preserves the Gut Microbiome of Patients With C. difficile Infection in Phase 2 TrialBy Nasdaq OMXMar 7, 2016, 12:00 PM UTC
BusinessSummit Therapeutics Announces Publication of Preclinical Data Showing Ridinilazole Outperformed Standard of Care in Reducing C. Difficile Toxins That Drive Disease SymptomsBy Nasdaq OMXFeb 24, 2016, 12:00 PM UTC
BusinessAssembly Biosciences to Webcast Upcoming Investor ConferencesBy Nasdaq OMXFeb 19, 2016, 12:30 PM UTC
BusinessCempra to Present at the Leerink Partners 5th Annual Global Healthcare ConferenceBy Nasdaq OMXFeb 3, 2016, 12:30 PM UTC
BusinessSummit Therapeutics Granted Key European Patent for Novel Antibiotic Ridinilazole for Treatment of C. Difficile InfectionBy Nasdaq OMXJan 19, 2016, 12:00 PM UTC
